Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Metformin Hydrochloride 500Mg Tablet
DRUG
2 trials
Sponsors
British Columbia Cancer Agency
, Ziauddin University
Conditions
Oral Submucous Fibrosis
Resectable Pancreatic Ductal Adenocarcinoma
Phase 1
Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis
Completed
NCT06871904
Ziauddin University
Oral Submucous Fibrosis
Start: 2025-04-07
End: 2025-12-30
Updated: 2026-02-03
Phase 2
The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma
NCT02978547
British Columbia Cancer Agency
Resectable Pancreatic Ductal Adenocarcinoma
Start: 2019-01-31
End: 2021-01-31
Target: 20
Updated: 2018-01-18
Related Papers
Oral Submucous Fibrosis in 2025: An Updated Narrative on Molecular Pathogenesis, Salivary Biomarkers, and Emerging Therapeutics
Zenodo (CERN European Organization for Nuclear Research)
2026-06-11
Oral Submucous Fibrosis in 2025: An Updated Narrative on Molecular Pathogenesis, Salivary Biomarkers, and Emerging Therapeutics
Zenodo (CERN European Organization for Nuclear Research)
2026-06-11